Samsung Electronics Co., Ltd.

Other

Catholic University Industry Academy Cooperation Foundation

Bio Clue & Solution Co., Ltd.

Korea Advanced Institute of Science and Technology

The Catholic University of Korea Industry-academic Cooperation Foundation

Catholic University Industry Academic Cooperation Foundation

Industry Academic Cooperation Foundation Hallym University

The Catholic University of Korea Industry-academic Cooperatior

Bio Clue & Solutions Co, Ltd.

Kim, Tae-yoon

Shin, Dong-heon

Tae-yoon Kim

Jae-Won Lee

Chang-woo Han

Sang-ha Kim

Sung-Soo Kim

Eun-kyoung Kim

Hyung-Joo Kwon

Jin-sik Lee

Doo-Sik Kim

Dong Heun Shin

Bo-Yeun Choung

Bo Jeong Pyun

Young-Ho Cho

Dong-Woo Lee

Sanghee Kim

Bong Ho Lee

Won Sik Eum

Yun Sang Lee

Young Guen Kwon

Jong Heon Shin

Soo Young Choi

Jinseu Park

Yang-Soon Kim

Dae-Won Kim

Jin-Hee Choi

Bo-Sung Ku

Young Geun Kwon

Yong-Soo Oh

Byung-Hak Kim

Jin-Sik Lee

Dong-Heon Shin

A speech signal processing method of a user terminal includes: receiving a speech signal, detecting a personalized information section including personal information in the speech signal, performing data processing on the personalized information section of the speech signal by using a personalized model generated based on the personal information, and receiving, from a server, a result of the data processing performed by the server on a general information section of the speech signal that is different than the personalized information section of the speech signal.

Speech signal processing method and speech signal processing apparatus

A device detects a wake-up keyword from a received speech signal of a user by using a wake-up keyword model, and transmits a wake-up keyword detection/non-detection signal and the received speech signal of the user to a speech recognition server. The speech recognition server performs a recognition process on the speech signal of the user by setting a speech recognition model according to the detection or non-detection of the wake-up keyword.

Speech recognition system and speech recognition method thereof

A speech recognition method includes: storing at least one acoustic model (AM); obtaining, from a device located outside the ASR server, a device ID for identifying the device; obtaining speech data from the device; selecting an AM based on the device ID; performing speech recognition on the speech data by using the selected AM; and outputting a result of the speech recognition.

Speech recognition method and apparatus using device information

A phytosphingosine derivative of chemical formula IA or IB, and a composition comprising the phytosphingosine derivative for preventing and treating inflammatory skin diseases, autoimmune diseases, and hyperkeratotic diseases. The phytosphingosine derivatives of the present disclosure are involved with transcription factors related to inflammation, autoimmune diseases and hyperkeratotic diseases, the expression and the generation of inflammatory mediators, signal transduction mechanisms, and the expression and the activity of relevant enzymes and the like.

Phytosphingosine derivatives, and composition comprising same for preventing and treating inflammatory skin diseases, autoimmune diseases, and hyperkeratosis diseases

The present invention relates to a new use of capsiate or dihydrocapsiate, more particularly to a composition for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease or for suppressing immunity comprising capsiate, dihydrocapsiate or a pharmaceutically acceptable salt thereof as an effective ingredient. The composition and immunosuppressant of the present invention may be used for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease, and for suppressing immunity.

Use of capsiate or dihydrocapsidate

The present invention relates to a method for preventing, alleviating or treating allergic diseases using capsiate or a pharmaceutically acceptable salt thereof. Capsiate or a pharmaceutically acceptable salt thereof according to the present invention may be used for the purpose of preventing, alleviating or treating allergic diseases.

Method for preventing or treating allergic disease using capsiate or salt thereof

There is provided a cell culture device, which includes a plurality of cell culture units, in which the cell culture unit includes: a cell culture tub that defines a culture space for cultivating cells, contains culture medium in the culture unit, and has an air layer above the culture medium; a drainage channel that is connected to the cell culture tub to discharge used culture medium to the integral drainage channel; an open culture medium reservoir that supplies new culture medium into the cell culture tub; and a droplet generator that is disposed between the cell culture tub and the open culture medium reservoir and supplies the culture medium from the open culture medium reservoir to the cell culture tub, using negative pressure of the air layer generated when the used culture medium is discharged.

Cell culture unit and cell culture device including the same

The present invention relates to an EC SOD and the use thereof. More particularly, the present invention relates to an EC SOD and the use thereof for preventing or treating skin diseases, particularly dermatitis or psoriasis.

EC SOD and use thereof

The present invention relates to novel use of sargachromenol, and more particularly, the present invention relates to novel use of sargachromenol for destroying and/or lysing hyperproliferating keratinocyte. Accordingly, since sargachromenol of the present invention has activity in destroying and/or lysing keratinocyte, it may be useful for keratinocyte lysing agents in the skin area where the keratinocytes are hyperproliferating or peeling agents.

Use of sargachromenol

Disclosed is the therapeutic use of CpG oligodeoxynucleotides for skin diseases. The CpG oligodeoxynucleotides (CpG ODNs) of the present invention show excellent immunoactive effects against skin diseases in both cases of CpG ODNs with a phosphorothioate backbone and CpG ODNs with a phosphodiester backbone.

Therapeutic use of CPG oligodeoxynucleotide for skin disease

Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.

Fusion protein comprising FK506 binding protein and DNA encoding the same

Disclosed are oligonucleotides for manipulating an immune reaction. The oligonucleotides of the present invention may be useful to stimulate the immune function, to treat the immune-related diseases and the atopic dermatitis, or to protect the normal immune cells.

[object Object]

Growing community of inventors

Seoul, South Korea

Tae-yoon Kim